{"transactions":[{"id":715458,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to buy)","published_at":"2026-07-06T21:51:21.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":476190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option shall vest on July 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":476190,"derivative":{"exercise_price":2.11,"expiration_date":"2036-07-01","underlying":"Common Stock","underlying_shares":476190},"source":{"system":"sec-edgar","filing":"0001851044-26-000005","document":"wk-form4_1783374679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000185104426000005/wk-form4_1783374679.xml","form_type":"4"}},{"id":715457,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-07-06T21:51:21.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":134530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal\nannual installments over the four-year period measured from July 20, 2026, subject to continued service through the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal\nannual installments over the four-year period measured from July 20, 2026, subject to continued service through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal\nannual installments over the four-year period measured from July 20, 2026, subject to continued service through the vesting date."}],"balance_after":134530,"derivative":{"underlying":"Common Stock","underlying_shares":134530},"source":{"system":"sec-edgar","filing":"0001851044-26-000005","document":"wk-form4_1783374679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000185104426000005/wk-form4_1783374679.xml","form_type":"4"}},{"id":919570,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Restricted Stock Unit","published_at":"2026-02-04T22:07:38.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":203307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal\nannual installments over the four-year period measured from February 2, 2026, subject to continued service through the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal\nannual installments over the four-year period measured from February 2, 2026, subject to continued service through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal\nannual installments over the four-year period measured from February 2, 2026, subject to continued service through the vesting date."}],"balance_after":203307,"derivative":{"underlying":"Common Stock","underlying_shares":203307},"source":{"system":"sec-edgar","filing":"0001737287-26-000002","document":"wk-form4_1770242855.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000173728726000002/wk-form4_1770242855.xml","form_type":"4"}},{"id":919569,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Stock Option (Right to buy)","published_at":"2026-02-04T22:07:38.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":718763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the stock option shall vest on February 2, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":718763,"derivative":{"exercise_price":1.87,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":718763},"source":{"system":"sec-edgar","filing":"0001737287-26-000002","document":"wk-form4_1770242855.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000173728726000002/wk-form4_1770242855.xml","form_type":"4"}},{"id":919568,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Common Stock","published_at":"2026-02-04T22:07:38.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":35700,"price":1.77,"value":63189.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election\nunder its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.71 to $1.87, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":581166,"source":{"system":"sec-edgar","filing":"0001737287-26-000002","document":"wk-form4_1770242855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000173728726000002/wk-form4_1770242855.xml","form_type":"4"}},{"id":932428,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Common Stock","published_at":"2026-01-23T21:15:10.000Z","date":"2026-01-21","kind":"sale","planned":false,"acquired":false,"shares":26269,"price":1.56,"value":40979.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":616866,"source":{"system":"sec-edgar","filing":"0001851044-26-000003","document":"wk-form4_1769202908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000185104426000003/wk-form4_1769202908.xml","form_type":"4"}},{"id":1282086,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Common Stock","published_at":"2025-02-05T21:12:55.000Z","date":"2025-02-03","kind":"sale","planned":false,"acquired":false,"shares":18832,"price":1.7,"value":32014.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election\nunder its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":643135,"source":{"system":"sec-edgar","filing":"0001737287-25-000016","document":"wk-form4_1738789969.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000173728725000016/wk-form4_1738789969.xml","form_type":"4"}},{"id":1293150,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Stock Option (Right to buy)","published_at":"2025-01-29T01:13:01.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":614844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":614844,"derivative":{"exercise_price":1.94,"expiration_date":"2035-01-24","underlying":"Common Stock","underlying_shares":614844},"source":{"system":"sec-edgar","filing":"0001737287-25-000006","document":"wk-form4_1738113175.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000173728725000006/wk-form4_1738113175.xml","form_type":"4"}},{"id":1293149,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Common Stock","published_at":"2025-01-29T01:13:01.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":173913,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":661967,"source":{"system":"sec-edgar","filing":"0001737287-25-000006","document":"wk-form4_1738113175.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000173728725000006/wk-form4_1738113175.xml","form_type":"4"}},{"id":1296489,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Common Stock","published_at":"2025-01-23T21:30:31.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":27199,"price":1.78,"value":48414.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in  connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.78 to $1.805, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with in the rage set forth above."}],"balance_after":488054,"source":{"system":"sec-edgar","filing":"0001737287-25-000003","document":"wk-form4_1737667821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000173728725000003/wk-form4_1737667821.xml","form_type":"4"}},{"id":1665342,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"officer":true,"officer_title":"EVP of R&D"}}],"security":"Stock Option (Right to buy)","published_at":"2024-01-31T22:45:39.000Z","date":"2024-01-25","kind":"grant","planned":false,"acquired":true,"shares":494949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter."}],"balance_after":494949,"derivative":{"exercise_price":3.2,"expiration_date":"2034-01-25","underlying":"Common Stock","underlying_shares":494949},"source":{"system":"sec-edgar","filing":"0001593968-24-000193","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000159396824000193/primary_01.xml","form_type":"4"}},{"id":1665341,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"officer":true,"officer_title":"EVP of R&D"}}],"security":"Common Stock","published_at":"2024-01-31T22:45:39.000Z","date":"2024-01-25","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":515253,"source":{"system":"sec-edgar","filing":"0001593968-24-000193","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000159396824000193/primary_01.xml","form_type":"4"}},{"id":1672189,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"officer":true,"officer_title":"EVP of R&D"}}],"security":"Common Stock","published_at":"2024-01-24T22:25:04.000Z","date":"2024-01-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":24690,"price":3.1744,"value":78375.936,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.15 to $3.205, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":375253,"source":{"system":"sec-edgar","filing":"0001593968-24-000142","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000159396824000142/primary_01.xml","form_type":"4"}},{"id":1939245,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"officer":true,"officer_title":"EVP of R&D"}}],"security":"Common Stock","published_at":"2023-03-25T00:16:40.000Z","date":"2023-03-22","kind":"grant","planned":false,"acquired":true,"shares":148035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance RSUs which shall vest as follows: (1) 33% shall vest if the 30-day weighted average stock price is equal to or greater than $18 and (2) 67% shall vest upon the first regulatory approval of a product candidate. Notwithstanding the foregoing (1) any portion that vests upon the stock price threshold shall no longer vest and be terminated after three years from the grant date if such threshold has not been met in such three-year period, and (2) any portion that vests upon product candidate approval shall no longer vest and be terminated after five years from the grant date if such approval has not occurred in such five-year period."}],"balance_after":399943,"source":{"system":"sec-edgar","filing":"0001593968-23-000525","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000159396823000525/primary_01.xml","form_type":"4"}},{"id":2047580,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-24T22:02:59.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":873015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on January 03, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":873015,"derivative":{"exercise_price":6.55,"expiration_date":"2033-01-20","underlying":"Common Stock","underlying_shares":873015},"source":{"system":"sec-edgar","filing":"0001737287-23-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000173728723000004/primary_doc.xml","form_type":"4"}},{"id":2047579,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Common Stock","published_at":"2023-01-24T22:02:59.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":251908,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":251908,"source":{"system":"sec-edgar","filing":"0001737287-23-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000173728723000004/primary_doc.xml","form_type":"4"}},{"id":2348214,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-07T22:10:14.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":245000,"price":8.62,"value":2111900.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":245000,"derivative":{"exercise_price":8.62,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":245000},"source":{"system":"sec-edgar","filing":"0001789769-22-000016","document":"wf-form4_164669099729627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000178976922000016/wf-form4_164669099729627.xml","form_type":"4"}},{"id":2545626,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-10-08T20:04:40.000Z","date":"2021-10-07","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents performance-based stock option previously granted to the Reporting Person by the Issuer on May 9, 2020. The performance conditions applicable to the award were determined to have been satisfied by the Issuer's Compensation Committee on October 7, 2021, resulting in the immediate vesting of the stock option as to 120,000 shares of Common Stock."}],"balance_after":240000,"derivative":{"exercise_price":0.83,"expiration_date":"2030-05-08","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001789769-21-000063","document":"wf-form4_163372346517423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000178976921000063/wf-form4_163372346517423.xml","form_type":"4"}},{"id":2572140,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-13T22:59:11.000Z","date":"2021-09-10","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents performance-based stock option previously granted to the Reporting Person by the Issuer on May 9, 2020. The performance conditions applicable to the award were determined to have been satisfied by the Issuer's Compensation Committee on September 10, 2021, resulting in the immediate vesting of the stock option as to 120,000 shares of Common Stock."}],"balance_after":120000,"derivative":{"exercise_price":0.83,"expiration_date":"2030-05-08","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001789769-21-000059","document":"wf-form4_163157393793773.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000178976921000059/wf-form4_163157393793773.xml","form_type":"4"}},{"id":2714693,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-13T20:54:09.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in forty-eight (48) equal monthly installments commencing on June 11, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":200000,"derivative":{"exercise_price":16.25,"expiration_date":"2031-05-10","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001789769-21-000036","document":"wf-form4_162093922749824.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000178976921000036/wf-form4_162093922749824.xml","form_type":"4"}},{"id":2776424,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-23T00:57:23.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in forty-eight (48) equal monthly installments commencing on March 19, 2021, subject to the Reporting Person continuing to provide service through each such\ndate."}],"balance_after":240000,"derivative":{"exercise_price":5.95,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001209191-21-022479","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000120919121022479/doc4.xml","form_type":"4"}}]}